Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Upperton is Launching an Enabling Technology Screening Protocol

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) are launching a platform which aims to support companies with the rapid development of both standard and complex drug products.

Read the rest of entry »

The Oxford Science Park: Green light for planning permission at Plot 16 as The Oxford Science Park continues ambitious expansion plans 

Oxford, UK, December 5 2019 - Oxford City Council’s East Area Planning Committee has approved the detailed plans for two office / laboratory buildings on The Oxford Science Park’s Plot 16 comprising 168,000 sq ft (15,600 sq m).  The plans feature a central raised plaza and wider landscaping and accessibility enhancements. 

Read the rest of entry »

Arecor announces positive headline results for the first Phase I clinical trial of AT247, a novel ultra rapid acting formulation of insulin

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces positive headline results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247.  In the study, AT247 provided a favourable pharmacokinetic/pharmacodynamic profile compared with NovoRapid® and Fiasp®.

Read the rest of entry »

UK-Based Absolute Antibody Partners with the Recombinant Antibody Network

Redcar, UK, December 3, 2019. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scale.

Read the rest of entry »

Data Magik launches our latest version of clinical trial system “Kapture”

Data Magik is proud to announce the launch of our latest version of clinical trial system “Kapture” and brand new website (

Read the rest of entry »

Aptus Clinical selected as clinical CRO by artelo biosciences

Aptus Clinical has been appointed full service clinical CRO partner by Artelo Biosciences Inc. (through their fully owned UK subsidiary, Trinity R&D Ltd). to deliver the upcoming Phase 1B/2A trial of their synthetic cannabinoid, ART27.13. This latest agreement builds on an earlier research and development partnership agreement, where Aptus successfully designed and supported the critical path pre-clinical experiments and completed key clinical strategy and planning activities for Artelo.

Read the rest of entry »

Precision for Medicine Significantly Expands Berlin Lab as Demand For Immune Monitoring Continues to Grow

BERLIN, GERMANY – 27 NOVEMBER 2019 – Precision for Medicine, part of Precision Medicine Group, today announced that they have opened a new 1,600 m2 Berlin-based laboratory, for the first time combining its proprietary Epiontis ID™ epigenetic immune-monitoring technology with advanced flow cytometry capabilities, along with a full-service biorepository and cell processing laboratory.

Read the rest of entry »

AMSBIO: ELRIG Recognize ScreenIn3D's Technical Innovation

ScreenIn3D, a partner of AMSBIO, has been awarded the prestigious ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019 which recently took place in Liverpool, UK.

Read the rest of entry »

OBN Monthly Newsletter for November!

Don't miss out on the November OBN update!

Read the rest of entry »

Oxford BioMaterials

This document lists the equipment belonging to Oxford Biomaterials.

Read the rest of entry »

Pages: Previous1234567...63NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.